Carregando...
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Although selective metabolic and receptor-based molecular agents will surely be included in the future of prostate cancer diagnosis and therapy, currently available inorganic compounds—such as (18)F-NaF for the diagnosis of bony disease and (223)RaCl(2) for the therapy of bone metastases—were recent...
Na minha lista:
| Publicado no: | J Nucl Med |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Society of Nuclear Medicine
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5093914/ https://ncbi.nlm.nih.gov/pubmed/27694165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.170746 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|